Related Experiment Video
Updated: Oct 4, 2025

11:58
Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
Published on: January 30, 2019
8.5K
Machine learning approaches to optimize small-molecule inhibitors for RNA targeting
Hadar Grimberg1, Vinay S Tiwari1, Benjamin Tam1
1Department of Chemistry and Data Science Research Center, Ben-Gurion University of the Negev, 8410501, Beer-Sheva, Israel.
Journal of Cheminformatics
|February 3, 2022
Summary
Data-driven algorithms identified novel phenylthiazole molecules. Four compounds potently inhibit Mycobacterium tuberculosis ribosomal peptidyl transferase center (PTC) hairpin 91, halting translation.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Molecular Biology
Background:
- Data-driven algorithms aid in discovering small molecules with specific biological targets.
- The ribosomal peptidyl transferase center (PTC) is a validated target for antimicrobial drug development.
Purpose of the Study:
- To develop data-driven algorithms for identifying phenylthiazole-containing molecules that bind to the Mycobacterium tuberculosis ribosomal PTC RNA hairpin.
- To guide the chemical space search for potent inhibitors of bacterial translation.
Main Methods:
- Utilized complementary data-driven algorithms to analyze molecular features for binding affinity.
- Synthesized 10 computationally identified small molecules for functional validation.
- Assessed inhibition of the ribosomal PTC in Mycobacterium tuberculosis.
Main Results:
- Identified key visual, geometrical, and chemical features enhancing binding to the target RNA hairpin.
- Four out of 10 synthesized molecules demonstrated potent inhibition of hairpin 91 in the ribosomal PTC.
- The identified inhibitors effectively halt bacterial translation.
Conclusions:
- Data-driven approaches are effective in discovering novel antimicrobial agents.
- Phenylthiazole derivatives targeting the M. tuberculosis ribosomal PTC represent a promising new class of antibiotics.
- Halting translation via inhibition of ribosomal function is a viable strategy against tuberculosis.
Related Concept Videos
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
RNA Interference
26.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.6K
siRNA - Small Interfering RNAs
17.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.1K
Types of RNA
69.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
69.1K
Nucleic Acid Structure
7.4K
The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
DNA Structure
DNA...
7.4K
Targets for Drug Action: Overview
7.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.8K

